Prospective Evaluation of the Carbon Footprint and Clinical Utility of IBUS Compared to Colonoscopy and Enterography in UC and CD
Condition(s) studied
Study summary
Healthcare contributes approximately 4.4% of global GHG emissions, with diagnostic imaging and endoscopic services being substantial contributors. Colonoscopy and cross-sectional imaging modalities, though indispensable, are associated with high carbon emissions due to electricity use, waste, sterilisation, and transportation. IBUS, a non-invasive, real-time diagnostic modality, is increasingly validated for disease activity assessment in both UC and CD.
Eligibility
Primary outcome measure(s)
- The electricity consumed, water consumed, waste generated, and Greenhouse Gas (GHG) emissions will be analyzed — 12 months
The waste generated will be stratified according to the methods of disposal as Direct landfill, Incineration, and landfill or Recyclable waste. The electricity consumed, water consumed, waste generated, and Greenhouse Gas (GHG) emissions will be analyzed. The unit of emissions will remain same kgCO2e and the total emissions will then be calculated.
Trial sites (2)
| Facility | City | Region | Status |
|---|---|---|---|
| AIG Hospitals | Hyderabad | Telangana | Recruiting |
| AIG Hospitals | Hyderabad | Telangana | Recruiting |
More Asian Institute of Gastroenterology, India trials in India
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07431983 on ClinicalTrials.gov ↗ ← All trials in India